Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for BunionectomyGlobeNewsWire • 09/21/22
Pacira Receives Positive CHMP Opinion for EXPAREL® for the Treatment of Postsurgical Pain in Children Aged 6 or OlderGlobeNewsWire • 09/20/22
Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022GlobeNewsWire • 09/13/22
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee ArthroplastyGlobeNewsWire • 09/07/22
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022GlobeNewsWire • 08/10/22
NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage PainGlobeNewsWire • 08/09/22
Pacira Biosciences Inc. (PCRX) CEO Dave Stack on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/02/22
Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022GlobeNewsWire • 07/27/22
Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/26/22
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 MillionGlobeNewsWire • 07/14/22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022GlobeNewsWire • 06/14/22
Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare ConferenceGlobeNewsWire • 06/02/22
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze DancePRNewsWire • 05/25/22
Pacira BioSciences' (PCRX) CEO Dave Stack on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22